Product logins

Find logins to all Clarivate products below.


Urological Devices | Market Insights | Europe | 2024

Driven by the increasing prevalence of kidney diseases, aging population, product innovation, and patient awareness of urological treatments in this region, the European urological device market will continue to expand through 2032, despite the short-term negative impact of the COVID-19 pandemic. Furthermore, favorable demographic trends, an increasing prevalence of obesity, adoption of premium devices, and the growing availability of less invasive treatment options will support urological procedure volume growth. Moreover, the rising use of minimally invasive laser treatments in Europe, where these techniques have been underpenetrated, will result in increased adoption of associated devices.

This Medtech 360 Report provides comprehensive data and analysis on the of the market for urological devices in Europe from 2019 through 2032.

Related Medtech Insights Reports

Report
Urological Devices – Market Insights – Latin America
The Latin American urological device market will continue to expand through 2034, driven by the rising prevalence of kidney stones and UI, aging populations, and growing patient awareness of…
Report
Biosurgical Agents – Market Insights – Europe
The Europe biosurgical agent market will exhibit modest growth over the forecast period. This expansion will be fueled by a continued preference for biosurgical agents over alternative solutions,…
Report
Trauma Devices – Market Insights – Europe
Although financial constraints among European healthcare facilities and the rise of GPOs that will exert downward pressure on ASPs will limit the European trauma device market, favorable…
Report
Infusion Pumps – Market Insights – Europe
The European infusion pump demand will be underpinned by aging populations and rising chronic disease, while accelerating adoption of closed-loop, EHR-integrated smart pumps and growing demand of…
Report
Physician-Dispensed Cosmeceuticals – Market Insights – Europe
The European physician-dispensed cosmeceutical market will be driven by rising aesthetic consciousness, an aging population, and increasing demand for clinically validated skincare solutions. The…